Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based COO’ operating in the Genetics space. If you think a COO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Mike Birch
Chief Operating Officer of F2G
Follow Mike Birch:
About F2G: F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.
Nick Lench
Chief Operating Officer & Chief Scientific Officer of Congenica
Nick was previously Director of the NE Thames Regional Genetics Service at Great Ormond Street Hospital for Children, London, with responsibility for the strategic and operational management of a genetics service that provides DNA diagnostic testing to a population of approximately 4.5M people. Nick is an honorary Reader at the UCL Institute of Child Health, London and has over 25 years of research experience in human molecular genetics and was awarded a personal chair in Medical Genetics at Cardiff University in 2005. As founding CEO of London Genetics Ltd and Programme Director at Oxagen Ltd, Nick has gained significant expertise in establishing and managing academic, healthcare and commercial partnerships in biomedical discovery and diagnostics.
Follow Nick Lench:
About Congenica: Congenica is a biotechnology company that provides a diagnostic decision support platform.
Victor Dillard
Founder , COO & CEO of Desktop Genetics
A former chemical engineer keen on seeing personalized treatment realized, Victor has spent the past three years leading Desktop Genetics’ business development and CRISPR genome-editing initiatives. He has closed several partnerships with leading life science companies, placing Desktop Genetics at the forefront of CRISPR therapeutics research. Informed by his previous experience at P&G, GlaxoSmithKline, Flagship Ventures, Victor believes that software will be the key to unlocking the full potential of biotech R&D. He holds MEng, Chemical Engineering from Imperial College London and an MPhil in Bioscience Enterprise from the University of Cambridge.
Follow Victor Dillard:
About Desktop Genetics: Desktop Genetics is an international company to help researchers discover and treat the root genetic causes of human disease.
Cliff Holloway
COO of Benitec Ltd
Cliff brings over 25 years of life science industry experience to Scancell in the development and commercialisation of emerging technologies and therapeutic products including licensing, M&A, corporate financing and operations management. Most recently he was Chief Business and Operating Officer of Benitec Biopharma Ltd (ASX:BLT, NASDAQ:BNTC). Prior to his role at Benitec he held the position of Managing Director at Sienna Cancer Diagnostics Ltd (ASX:SDX), and also for therapeutic antibody development companies Immune System Therapeutics Ltd and Biosceptre International Ltd. He was formerly VP of Business Development at Arana Therapeutics Ltd, which was acquired by US-based Cephalon Inc (now Teva) in 2009, and he is currently a director of investment fund Newstar Ventures Pty Ltd. Cliff holds a Bachelor of Pharmacy and a PhD in Medicinal Chemistry from the University of Nottingham.
Follow Cliff Holloway:
About Benitec Ltd, Newstar Ventures Pty Ltd., Scancell: Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases.
Rory Cameron
Chief Operating Officer of Gendius
Rory has a proven track record in starting up Pharmaceutical businesses in many different specialised sectors. Rory’s most recent role was as SVP and GM at InterMune UK&I where he set up the UK and Irish businesses over a 4 year period until their successful acquisition by Roche. Rory’s background is in Sales and Marketing and he has a passion for ensuring we improve the delivery of care to patients.
Follow Rory Cameron:
About Gendius: Gendius is a diabetes management platform helping its consumers check and level diabetes.
